Utilization of a Postpartum Fasting Blood Glucose to Predict Impaired Glucose Tolerance in Patients with Gestational Diabetes Mellitus

Abstract

Objective

The Endocrine Society recommends a postpartum fasting blood glucose (FBG) be performed for patients with gestational diabetes mellitus (GDM) prior to hospital discharge to screen for ongoing hyperglycemia. There are limited data, however, on whether an FBG can screen for glucose intolerance and if it correlates with the gold standard 4- to 12-week 2-hour oral glucose tolerance test (OGTT). Our objective was to evaluate if FBG correlates with the gold standard 2-hour OGTT.

Study Design

This retrospective cohort study of patients with GDM who delivered >20 weeks' gestation at two urban centers from January 2017 to December 2020 included those who completed both a postpartum FBG prior to discharge and a 2-hour 75-g OGTT within 1 year of delivery. Abnormal 2-hour OGTT was defined as fasting value ≥100 mg/dL and/or 2-hour value ≥140 mg/dL. We evaluated test characteristics (e.g., sensitivity, specificity) of postpartum FBG cut-offs to predict an abnormal 2-hour OGTT result.

Results

A total of 235 patients met inclusion criteria, of which 63% were diet-controlled and 37% required medical management. FBG ranged from 64 to 134 mg/dL, with 6/235 (2.6%) with values ≥126 mg/dL. A total of 39/235 (16.6%) of patients had an abnormal 2-hour OGTT. Overall, area under the curve for FBG predicting abnormal 2-hour OGTT was 0.65. Traditionally considered high cut-offs (≥126 mg/dL) for predicting persistent impaired glucose intolerance demonstrated poor positive predictive value (PPV; <20%). In contrast, low cut-offs demonstrated excellent NPV (>90%). A postpartum FBG of 88 mg/dL was determined to be the optimal cut-off for FBG with NPV = 92.4% (Youden index = 0.34). In this dataset, if FBG ≥ 88 mg/dL was used to determine if 2-hour OGTT was required, almost half of GDM patients could avoid further glucose tolerance testing.

Conclusion

While previously thought of as best utilized for its PPV, the FBG may be best used for its NPV. In our study, clinical application of an FBG < 88 mg/dL was highly correlative with a normal 2-hour OGTT.

Key Points

• Screening for postpartum glucose intolerance is essential for gestational diabetes.

• A promising initiative includes offering screening tests while in the hospital, including an FBG.

• Application of a postpartum FBG < 88 mg/dL is highly correlative with a normal 2-hour OGTT.

Keywords

fasting - gestational diabetes - glucose - hyperglycemia - oral glucose tolerance test - postpartum - screening test

Publikationsverlauf

Eingereicht: 03. Juli 2024

Angenommen: 17. September 2024

Accepted Manuscript online:
17. September 2024

Artikel online veröffentlicht:
01. Oktober 2024

• References

• 1 Kim C, Newton KM, Knopp RH. Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care 2002; 25 (10) 1862-1868
• 2 Kaaja RJ, Greer IA. Manifestations of chronic disease during pregnancy. JAMA 2005; 294 (21) 2751-2757
• 3 Russell MA, Phipps MG, Olson CL, Welch HG, Carpenter MW. Rates of postpartum glucose testing after gestational diabetes mellitus. Obstet Gynecol 2006; 108 (06) 1456-1462
• 4 Practice Bulletin No. Practice bulletin no. 137: gestational diabetes mellitus. Obstet Gynecol 2013; 122 (2 Pt 1): 406-416
• 5 Pastore I, Chiefari E, Vero R, Brunetti A. Postpartum glucose intolerance: an updated overview. Endocrine 2018; 59 (03) 481-494
• 6 Blumer I, Hadar E, Hadden DR. et al. Diabetes and pregnancy: an endocrine society clinical practice guideline. [published correction appears in J Clin Endocrinol Metab. 2016;101(1):343] [published correction appears in J Clin Endocrinol Metab. 2022;107(9):e3972] J Clin Endocrinol Metab 2013; 98 (11) 4227-4249
• 7 Ratner RE, Christophi CA, Metzger BE. et al; Diabetes Prevention Program Research Group. Prevention of diabetes in women with a history of gestational diabetes: effects of metformin and lifestyle interventions. J Clin Endocrinol Metab 2008; 93 (12) 4774-4779
• 8 Werner EF, Has P, Tarabulsi G, Lee J, Satin A. Early postpartum glucose testing in women with gestational diabetes mellitus. [published correction appears in Am J Perinatol. 2016;33(14):1433–1434] Am J Perinatol 2016; 33 (10) 966-971
• 9 Werner EF, Has P, Rouse D, Clark MA. Society for Maternal-Fetal Medicine (SMFM). Two-day postpartum compared with 4- to 12-week postpartum glucose tolerance testing for women with gestational diabetes. Am J Obstet Gynecol 2020; 223 (03) 439.e1-439.e7
• 10 Prior AK, Dolin CD, Bender W, Durnwald CP, Hamm RF. Effects of implementing a routine postpartum fasting blood glucose on the completion of the gold standard 2-hour oral glucose tolerance test in gestational diabetics. Am J Perinatol 2024
• 11 Kim C, Tabaei BP, Burke R. et al. Missed opportunities for type 2 diabetes mellitus screening among women with a history of gestational diabetes mellitus. Am J Public Health 2006; 96 (09) 1643-1648
• 12 Middleton P, Crowther CA. Reminder systems for women with previous gestational diabetes mellitus to increase uptake of testing for type 2 diabetes or impaired glucose tolerance. Cochrane Database Syst Rev 2014; 2014 (03) CD009578
• 13 Mendez-Figueroa H, Daley J, Breault P. et al. Impact of an intensive follow-up program on the postpartum glucose tolerance testing rate. Arch Gynecol Obstet 2014; 289 (06) 1177-1183
• 14 Carson MP, Frank MI, Keely E. Original research: postpartum testing rates among women with a history of gestational diabetes–systematic review. Prim Care Diabetes 2013; 7 (03) 177-186